SG12473

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameSG12473
Drug Alias NameSG12473SG-12473
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 blockersCluster of differentiation 47 inhibitors
TargetsProgrammed death-ligand 1Cluster of differentiation 47
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesHangzhou Shangjian Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesChina Gateway Biologics (Shanghai) Co LtdHangzhou Shangjian Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A